Similarly, in GC, METTL3 promotes tumor angiogenesis through the ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9)-mediated PI3K/AKT pathway [99]. The gene discussed is METTL3; the disease is neoplasm.